Merck & Co Inc (MRK)

58.97
0.37 0.63
NYSE : Health Care
Prev Close 58.60
Open 58.51
Day Low/High 58.11 / 58.59
52 Wk Low/High 45.69 / 60.07
Volume 7.29M
Avg Volume 8.76M
Exchange NYSE
Shares Outstanding 2.77B
Market Cap 162.21B
EPS 1.60
P/E Ratio 35.95
Div & Yield 1.84 (3.10%)

Latest News

Merck Shares Rise After Second-Quarter Earnings Top Forecasts

Merck Shares Rise After Second-Quarter Earnings Top Forecasts

Merck raises the floor of guidance for full-year non-GAAP earnings per share and is now targeting between $3.67 and $3.77.

Financial Highlights Package

Financial Highlights Package

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2016.

What to Watch Friday: Anheuser-Busch Inbev Reports Earnings, Q2 GDP Estimate

What to Watch Friday: Anheuser-Busch Inbev Reports Earnings, Q2 GDP Estimate

On Friday, July 29, investors will get quarterly results from Anheuser-Busch Inbev and the first estimate of second quarter GDP.

Merck (MRK) Stock Down Ahead of Q2 Earnings

Merck (MRK) Stock Down Ahead of Q2 Earnings

Merck (MRK) stock is slipping this morning as the company expects to post fiscal 2016 second quarter results before tomorrow's market open.

Buy Gilead Sciences While It's Wallowing

Buy Gilead Sciences While It's Wallowing

It's too cheap for a biotech giant with years of patent protection for key products and great cash flow.

Merck Announces Fourth-Quarter 2016 Dividend

Merck Announces Fourth-Quarter 2016 Dividend

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.

Merck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review

Merck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review

Merck (MRK) announced that its experimental Ebola vaccine V920 has been put under 'accelerated' review in the U.S. and the EU.

Merck Receives Breakthrough Therapy Designation From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine (V920)

Merck Receives Breakthrough Therapy Designation From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine (V920)

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced two regulatory milestones for the company's investigational vaccine for Ebola Zaire, V920 (rVSV¿G-ZEBOV-GP, live attenuated): the U.

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

A slew of corporate earnings and closely watched Federal Reserve meeting are in focus for the week of July 25.

Do the Math! Stocks Are Poised for a Fall

Do the Math! Stocks Are Poised for a Fall

Optimism is warranted over the long haul, but investors probably face a short-term headache. Here are the crucial numbers and events to watch in the week ahead.

Week Ahead: Fed's July Meeting Overshadows Another Busy Earnings Week

Week Ahead: Fed's July Meeting Overshadows Another Busy Earnings Week

The Federal Reserve will steal focus from another onslaught of earnings in the coming week as investors remain wary over the central bank's rate-hike timetable.

Data For Merck's Investigational Once-Daily Formulation Of ISENTRESS® (raltegravir) Show That At Week 48, A Regimen Containing The Once-Daily Dosing Formulation...

Data For Merck's Investigational Once-Daily Formulation Of ISENTRESS® (raltegravir) Show That At Week 48, A Regimen Containing The Once-Daily Dosing Formulation...

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced efficacy and safety data in previously untreated adults with HIV-1 infection for the company's investigational once-daily formulation of...

Merck Animal Health Receives FDA Approval Of BRAVECTO® (fluralaner Topical Solution) For Cats And Dogs

Merck Animal Health Receives FDA Approval Of BRAVECTO® (fluralaner Topical Solution) For Cats And Dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced the U.

Merck Provides Regulatory Update On Biologics Licensing Application For Investigational Agent Bezlotoxumab

Merck Provides Regulatory Update On Biologics Licensing Application For Investigational Agent Bezlotoxumab

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that the U.

These 5 Big Stocks Are Breaking Out This Summer

These 5 Big Stocks Are Breaking Out This Summer

Earnings season is off to a good start. Here are five more stocks that could shoot higher this summer.

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.

Here's When You Should Buy Merck

Here's When You Should Buy Merck

A pullback for Merck will lead to lower entry opportunities.

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.

Merck (MRK) Stock Slides, BMO Downgrades

Merck (MRK) Stock Slides, BMO Downgrades

BMO Capital Markets downgraded Merck (MRK) stock to ‘market perform’ today.

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Here are Monday's top research calls, including upgrades for Groupon and Humana, and downgrades for Monster Beverage and Merck.

Cramer: These Stocks Are the Key to the Bull Market

Cramer: These Stocks Are the Key to the Bull Market

Let me give you the unassailable themes.

FB, AMZN and NFLX: Jim Cramer's Views

FB, AMZN and NFLX: Jim Cramer's Views

Cramer shares his views on why he thinks this market is not finished. Facebook, Amazon and Netflix are among the stocks discussed.

3 Stocks Dragging In The Drugs Industry

3 Stocks Dragging In The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Cramer: Beware the Worst Bond Money Can Buy

Cramer: Beware the Worst Bond Money Can Buy

I care about making and preserving my clients' money.

Closing Bell: Airlines Rally on Deutsche Bulls; U.S. Stocks at Records

Closing Bell: Airlines Rally on Deutsche Bulls; U.S. Stocks at Records

An earlier rally lasted through the afternoon, pushing the S&P 500 and Dow Jones Industrial Average to close at fresh records.

Merck (MRK) Stock Gaining, Cutting Research Jobs

Merck (MRK) Stock Gaining, Cutting Research Jobs

Merck (MRK) announced that it would be laying off research and development employees at three east-coast sites.

X(encor) Marks the Spot For Potential Gains

X(encor) Marks the Spot For Potential Gains

You have to be impressed by the breadth of XNCR's pipeline and significant partnerships with major players.

3 Stocks Improving Performance Of The Drugs Industry

3 Stocks Improving Performance Of The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.